<DrugInformationSummary id="CDR0000809237"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>This page contains brief information about lutetium Lu 177 vipivotide tetraxetan
         and a collection of links to more information about the use of 
         this drug, research results, and ongoing clinical trials.
  </DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/lutetium-Lu-177-vipivotide-tetraxetan">Lutetium Lu 177 Vipivotide Tetraxetan</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000792497">lutetium Lu 177 vipivotide tetraxetan</TerminologyLink><GlossaryLink ref="CDR0000809191">lutetium Lu 177 vipivotide tetraxetan</GlossaryLink><USBrandNames><USBrandName>Pluvicto</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>loo-TEE-shee-um â€¦ vy-PIH-voh-tide teh-TRAK-seh-tan</TermPronunciation><MediaLink ref="CDR0000809838" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000809839" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb973a8d-7fea-4a7a-963f-2a8e67a46e55&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Lutetium Lu 177 Vipivotide Tetraxetan</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb973a8d-7fea-4a7a-963f-2a8e67a46e55&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Lutetium Lu 177 vipivotide tetraxetan
         is approved to treat:</Para>                          
  <ItemizedList Style="bullet" id="_3">
   <ListItem><Strong><GlossaryTermRef href="CDR0000445079" dictionary="Cancer.gov" audience="Patient">Prostate cancer</GlossaryTermRef></Strong> that produces high levels of the <GlossaryTermRef href="CDR0000804938" dictionary="Cancer.gov" audience="Patient">PSMA</GlossaryTermRef> protein, has not responded to treatments that lower <GlossaryTermRef href="CDR0000045581" dictionary="Cancer.gov" audience="Patient">testosterone</GlossaryTermRef> levels, and has spread to other parts of the body.  It is used in adults who received an <GlossaryTermRef href="CDR0000797801" dictionary="Cancer.gov" audience="Patient">androgen receptor blocker</GlossaryTermRef> and can either delay or have received treatment with  <GlossaryTermRef href="CDR0000046138" dictionary="Cancer.gov" audience="Patient">taxane</GlossaryTermRef>-based chemotherapy.</ListItem>
   </ItemizedList>
  
 </Section><Section id="_About"><Title>More About Lutetium Lu 177 Vipivotide Tetraxetan</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792497">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.3">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a622063.html">Lutetium Lu 177 Vipivotide Tetraxetan</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.4"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.5">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C148145">Find Clinical Trials for Lutetium Lu 177 Vipivotide Tetraxetan</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2022-04-26</DateFirstPublished><DateLastModified>2025-04-07</DateLastModified></DrugInformationSummary>
